Treatment of phaeochromocytoma and of clonidine withdrawal hypertension with labetalol.

Rosei, E A; Brown, J J; Lever, A F; Robertson, A S; Robertson, J I; Trust, P M

Rosei, E A; Brown, J J; Lever, A F; Robertson, A S; Robertson, J I; Trust, P M.

Br J Clin Pharmacol ; 3(4 Suppl 3): 809-15, 1976 Aug.

Article in En | MEDLINE | ID: mdl-990158

Subject(s)

Clonidine; Ethanolamines/therapeutic use; Hypertension/drug therapy; Labetalol/therapeutic use; Pheochromocytoma/drug therapy; Substance Withdrawal Syndrome/complications; Administration, Oral; Adult; Clonidine/therapeutic use; Drug Evaluation; Female; Humans; Hypertension/etiology; Injections, Intravenous; Labetalol/administration & dosage; Male; Middle Aged

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pheochromocytoma / Substance Withdrawal Syndrome / Clonidine / Ethanolamines / Hypertension / Labetalol Type of study: Etiology_studies Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: Br J Clin Pharmacol Year: 1976 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links